Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$3.65M Buy
149,922
+60,298
+67% +$1.52M ﹤0.01% 2335
2014
Q2
$2.27M Sell
89,624
-25,897
-22% -$605K ﹤0.01% 2755
2014
Q1
$2.48M Buy
115,521
+31,935
+38% +$689K ﹤0.01% 2567
2013
Q4
$1.87M Buy
83,586
+22,528
+37% +$497K ﹤0.01% 2862
2013
Q3
$1.26M Sell
61,058
-51,392
-46% -$1.09M ﹤0.01% 3081
2013
Q2
$2.17M Buy
+112,450
New +$2.35M ﹤0.01% 2460

Other funds holding HOLX

UBS's HOLX Position: Q3 2014 in Review

UBS increased its Hologic (HOLX) stake by 67% in Q3 2014, buying an estimated $1.52M and bringing the position to 149,922 shares worth $3.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

UBS first reported a position in HOLX in Q2 2013 and has held it in 6 quarters since. 353 funds tracked by Wall St. Rank hold HOLX as of Q3 2014.

  • UBS held 149,922 shares of Hologic worth $3.65M as of Q3 2014.
  • UBS bought 60,298 Hologic shares in Q3 2014, an estimated $1.52M.
  • Hologic made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2335 holding.
  • UBS first reported a position in Hologic in Q2 2013 and has held it in 6 quarters since.
  • 353 funds tracked by Wall St. Rank held Hologic as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.